Table 1.
CE (n = 33) | LAA (n = 42) | SVO (n = 41) | ICH (n = 36) | TIA (n = 31) | Control (n = 22) | p value | |
---|---|---|---|---|---|---|---|
Sex male n (%) | 28 (85) | 30 (71) | 28 (68) | 27 (75) | 19 (61) | 14 (64) | 0.232 |
Age: years ± SE | 65.2 ± 2.0 | 61.6 ± 1.4 | 65.3 ± 1.1 | 62.5 ± 2.4 | 65.1 ± 2.1 | 63.2 ± 2.0 | 0.496 |
Hypertension n (%) | 27 (81.8) | 35 (83.3) | 34 (82.9) | 31 (86.1) | 24 (77.4) | 12 (54.6) | 0.069 |
Diabetes n (%) | 9 (27.3) | 18 (42.9) | 23 (56.1) | 11 (30.6) | 10 (32.3) | 7 (31.8) | 0.095 |
Hyperlipidemia n (%) | 16 (48.5) | 22 (52.4) | 25 (61.0) | 11 (30.6) | 20 (64.5) | 9 (40.9) | 0.054 |
AF (%) | 18 (54.5) | 2 (4.8) | 5 (12.2) | 3 (8.3) | 3 (9.7) | 0 (0) | < 0.001* |
CAD (%) | 10 (30.3) | 10 (23.8) | 3 (7.3) | 6 (16.7) | 7 (22.6) | 0 (0) | 0.023** |
CHF (%) | 2 (6.1) | 1 (2.4) | 1 (2.4) | 1 (2.8) | 4 (12.9) | 0 (0) | 0.181 |
Dementia n (%) | 1 (3.0) | 0 (0) | 0 (0) | 1 (2.8) | 0 (0) | 0 (0) | 0.551 |
Parkinson’s disease n (%) | 1 (3.0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.388 |
NIHSS: median (IQR) | 5 (1–10.25) | 3 (1–5) | 4 (2–7) | 4 (1–7) | 0 (0–1) | – | < 0.001 |
CE cardioembolic, LAA large artery atherosclerosis, SVO small-vessel occlusion, TIA transient ischemic attack, AF atrial fibrillation, CAD coronary artery disease, CHF congestive heart failure, SE standard error of the mean, NIHSS National Institutes of Health Stroke Scale, IQR Interquartile range.
*p value for chi-square of total 6 groups. CE to control: p < 0.001; LAA to control: p = 0.542; SVO to control: p = 0.153; ICH to control: p = 0.281; TIA to control: p = 0.258.
**p value for chi square of total 6 groups. CE to control: p = 0.004; LAA to control: p = 0.012; SVO to control: p = 0.546; ICH to control: p = 0.073; TIA to control: p = 0.033.